FARMA-TOSSICOLOGIA DELLO SPORT

Amelia FILIPPELLI FARMA-TOSSICOLOGIA DELLO SPORT

4412500054
DEPARTMENT OF HUMAN, PHILOSOPHIC AND EDUCATION SCIENCES
EQF6
SCIENZE DELLE ATTIVITA' MOTORIE, SPORTIVE E DELL'EDUCAZIONE PSICOMOTORIA
2023/2024

YEAR OF COURSE 2
YEAR OF DIDACTIC SYSTEM 2017
SPRING SEMESTER
CFUHOURSACTIVITY
636LESSONS
Objectives
THE COURSE AIMS TO PROVIDE KNOWLEDGE OF THE FUNDAMENTALS OF PHARMACOLOGY IN A WAY
MAKING IT POSSIBLE UNDERSTANDING THE RISKS AND BENEFITS ASSOCIATED WITH THE USE OF DRUGS AND
OF SUBSTANCES.
DURING THE COURSE, TOPICS OF GENERAL PHARMACOLOGY WILL BE ADDRESSED WHICH INCLUDE:
PHARMACOKINETICS, PHARMACODYNAMICS, DRUG RESEARCH AND DEVELOPMENT, PHARMACOVIGILANCE,
SAFETY AND TOXICITY OF DRUGS, PHARMACOLOGICAL INTERACTIONS.
SOME SPECIAL PHARMACOLOGY ARGUMENTS FACING KNOWLEDGE WILL THEN BE TREATED
OF THE EFFECTS OF SOME OF THE CLASSES OF DRUGS MOST FREQUENTLY USED IN THE ENVIRONMENT
SPORTY.
THANKS TO THIS KNOWLEDGE THE STUDENT WILL ACQUIRE THE CRITICAL SKILLS TO INTERPRET THE
PROBLEMS, RISKS AND BENEFITS RELATED TO THE USE OF DRUGS AND SUBSTANCES.

KNOWLEDGE AND UNDERSTANDING
- FUNDAMENTALS OF PHARMACOLOGY AND THE USE OF THE MOST FREQUENT DRUG CLASSES
USED IN A SPORTS ENVIRONMENT;
- GENERAL KNOWLEDGE ON THE MAIN CATEGORIES OF DRUGS, ON THEIR CHARACTERISTICS
PHARMACOKINETICS, PHARMACODYNAMICS, THE RATIONALE OF THEIR THERAPEUTIC USE AND
POSSIBLE SIDE EFFECTS;

ABILITY TO APPLY KNOWLEDGE AND UNDERSTANDING:
- ABILITY TO RECOGNIZE THE RISKS AND BENEFITS OF USING THE DRUG AND / OR SUBSTANCES;
- ABILITY TO UNDERSTAND THE INFORMATION CONTAINED IN THE MEDICINES SHEETS OF MORE
FREQUENT USE, SO AS TO BE A REFERENCE FOR INFORMATION AND CULTURE OF THE
HEALTH IN THE SPORTS AREA.

Prerequisites
THERE ARE NO PROPEDEUTICITY OR BARRINGS TO SUPPORT THE EXAM TEACHING
ASSUMES THE KNOWLEDGE OF WHAT YOU LEARN IN THE BIOCHEMISTRY AND PHYSIOLOGY COURSES OF
MOVEMENT.
Contents
DURING THE COURSE THE FOLLOWING TOPICS WILL BE ADDRESSED:
GENERAL PHARMACOLOGY (18 HOURS, LECTURES): CONCEPT OF DRUG AND WAYS OF
ADMINISTRATION; PHARMACOKINETICS AND PHARMACODYNAMICS; PHARMACOKINETIC MODIFICATIONS E
PHARMACODYNAMICS RELATED TO PHYSICAL EXERCISE; INTERACTIONS BETWEEN DRUGS; PHARMACOVIGILANCE
AND CLINICAL TRIAL; DRUG SAFETY AND TOXICITY, DRUG ABUSE.
SPECIAL PHARMACOLOGY (18 HOURS, LECTURES): PHARMACOLOGY OF THE CHOLINERGIC SYSTEM AND
ADRENERGIC; STIMULANTS OF THE CENTRAL NERVOUS SYSTEM; PHARMACOTHERAPY OF DYSFUNCTIONS
CARDIOVASCULAR; ACTIVE DRUGS ON THE RESPIRATORY SYSTEM; HYPOGLYCAEMIC,
HYPOLIPIDEMIC PRODUCTS, PAIN THERAPY, ANTI-INFLAMMATORS, MYORELAXANTS.

Teaching Methods
THE COURSE INCLUDES 36 TOTAL HOURS OF LECTURES, DIVIDED IN THIS WAY: 18 HOURS
DEDICATED TO TEACHING GENERAL PHARMACOLOGY; 18 HOURS TO THE TEACHING OF
SPECIAL PHARMACOLOGY. PARTICIPATION IN LECTURES IS NOT OBLIGATORY, BUT
STRONGLY RECOMMENDED FOR THE PURPOSE OF LEARNING THE TOPICS THAT WILL BE DISCUSSED IN
EXAMINATION PLACE.
Verification of learning
THE ACHIEVEMENT OF THE OBJECTIVES OF THE TEACHING IS GLOBALLY VERIFIED THROUGH THE
PASSING AN EXAM. THE EXAM INCLUDES AN ORAL TEST. THE ORAL EXAM CONSISTS OF ONE
INTERVIEW WITH QUESTIONS AND DISCUSSION OF THE DURATION OF ABOUT 30 MINUTES. IT IS AIMED AT
ASK FOR THE LEVEL OF KNOWLEDGE AND UNDERSTANDING REACHED BY THE STUDENT ABOUT THE
THEMES COVERED DURING THE LESSONS, AS WELL AS CHECKING THE EXPOSURE CAPABILITY, MAKING
THE APPROPRIATE TERMINOLOGY, AND THE ABILITY OF AUTONOMOUS EXPOSURE ORGANIZATION
OF THE SAME TOPICS WITH THEORETICAL CONTENT. THE TEST IS ASSESSED IN THIRTIES AND IT IS INTENDED
EXCEEDED WITH THE MINIMUM VOTE OF 18/30.
Texts
“COMPENDIO DI FARMACOLOGIA GENERALE E SPECIALE” DI AMICO ROXAS - CAPUTI - DEL TACCA ISBN:
9788821453458 EDRA – MASSON, EDIZIONE: II 2021
"LE BASI DELLA FARMACOLOGIA" DI MICHELLE A. CLARCK, RICHARD FINKEL, JOSE A. REY, KAREN WHALEN
ED. ZANICHELLI, III EDIZIONE (2020)
“FARMACOLOGIA GENERALE E MOLECOLARE” DI F. CLEMENTI, G. FUMAGALLI, ED. EDRA, V EDIZIONE
(2018)
More Information
OPTIONAL COURSE OF THE STUDENT'S CHOICE.
FURTHER INFORMATION MAY BE REQUESTED VIA E-MAIL: AFILIPPELLI@UNISA.IT;
  BETA VERSION Data source ESSE3 [Ultima Sincronizzazione: 2024-11-05]